Evidence map›Paper›PMID 42708682›Full record

ArticleJournal of chemical theory and computation2026

Disease-Associated Mutations Impact DNA Methyltransferase 1 Function through Dynamic Allosteric Effects and Solvent Exposure.

Song Xie, Can Bora Yildiz, Paolo Ruggerone, Ke Zuo, Geraldine Zimmer-Bensch, Paolo Carloni

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Song XieInstitute of Neuroscience and Medicine (INM-9) Computational Biomedicine , Forschungszentrum Jülich GmbH, Jülich52428, Germany.
Can Bora YildizRWTH Aachen University , Department of Neuroepigenetics, Institute of Zoology (Biology 2), Worringerweg 3, 52074Aachen, Germany.
Paolo RuggeroneDepartment of Physics, University of Cagliari, Cittadella Universitaria, S.P.monserrato-Sestu Km 0.700, Monserrato (CA)I-09044, Italy.
Ke ZuoCollege of Pharmacy (International Academy of Targeted Therapeutics and Innovation), Chongqing University of Arts and Sciences, Chongqing402160, PR China.
Geraldine Zimmer-BenschRWTH Aachen University , Department of Neuroepigenetics, Institute of Zoology (Biology 2), Worringerweg 3, 52074Aachen, Germany.
Paolo CarloniInstitute of Neuroscience and Medicine (INM-9) Computational Biomedicine , Forschungszentrum Jülich GmbH, Jülich52428, Germany.ORCID 0000-0002-9010-0149

Funding

China Scholarship Council 202306650006Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany?s Excellence Strategy 368482240/GRK2416Italy?s National Recovery and Resilience Plan (NRRP), Mission 4-Component 2-Investment 1.1, Call No. 104 CUP F53D23001170006
6 · The paper itself

Abstract

Mutations in the DNA methyltransferase 1 (DNMT1) enzyme can lead to neurodegenerative diseases, including autosomal dominant cerebellar ataxia-deafness and neuropathy (ADCA-DN) and hereditary sensory and autonomic neuropathy type 1E (HSAN1E). The impact of these mutations on the structural dynamics of DNMT1 remains largely unknown. Here, we present an extensive molecular dynamics investigation of wild-type (WT) DNMT1 and its mutants associated with ADCA-DN (A554V, G589A, and V590F) and HSAN1E (D490E-P491Y and Y495C). The first group of mutants increases structural flexibility and disrupts the allosteric communication relative to WT DNMT1. These findings provide a molecular explanation for the reduced in vitro thermostability observed in these mutants. The second group has a similar impact on structural flexibility and allosteric communication and increases solvent exposure at mutant sites, offering a plausible structural explanation for the experimentally observed aberrant protein degradation and cleavage. Furthermore, all the investigated variants alter the most significant large-scale motions of the enzyme. This disruption of motion, together with decreased structural stability, may affect DNMT1's molecular recognition processes with its cellular partners. Overall, this study sheds light on the molecular mechanisms underlying ADCA-DN and HSAN1E, which could inform the development of therapies.

Indexed as

DNA (Cytosine-5-)-Methyltransferase 1Hereditary Sensory and Autonomic NeuropathiesMolecular Dynamics SimulationMutationSolventsAllosteric RegulationHumansDNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanSolvents

Identifiers

PMID42708682
PMCPMC13564358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.